Log in to save to my catalogue

Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic revi...

Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic revi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_135cb09724d342efacc26f20041cce1c

Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis

About this item

Full title

Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis

Publisher

England: John Wiley & Sons, Inc

Journal title

ESC Heart Failure, 2022-10, Vol.9 (5), p.3188-3197

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims
Aortic stenosis (AS) and cardiac amyloidosis (CA) are typical diseases of the elderly. Up to 16% of older adults with severe AS referred to transcatheter aortic valve replacement (TAVR) have a concomitant diagnosis of CA. CA‐AS population suffers from reduced functional capacity and worse prognosis than AS patients. As the prognostic impact...

Alternative Titles

Full title

Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_135cb09724d342efacc26f20041cce1c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_135cb09724d342efacc26f20041cce1c

Other Identifiers

ISSN

2055-5822

E-ISSN

2055-5822

DOI

10.1002/ehf2.13876

How to access this item